Back to Results
First PageMeta Content
Health / Center for Drug Evaluation and Research / Hypogonadism / Testosterone / Dermatologic and Ophthalmic Drugs Advisory Committee / Oncology Drug Advisory Committee / Food and Drug Administration / Medicine / Endocrine system


Microsoft Word - AGENDA BRUDAC_Sept 18v2.doc
Add to Reading List

Open Document

File Size: 13,24 KB

Share Result on Facebook

City

Hyattsville / /

Company

SPONSOR PRESENTATIONS Clarus Therapeutics Inc. / MMSc / PhD / /

Facility

Potomac Ballroom / University of Maryland University College / College Park Marriott Hotel / Cellular Biology Baylor College of Medicine Effectiveness Merrell Magelli / University Blvd. East / /

MedicalCondition

hypogonadotropic hypogonadism / primary hypogonadism / deficiency / MS / /

MedicalTreatment

testosterone replacement therapy / /

Organization

Drug Safety and Risk Management Advisory Committee / Bone / Reproductive and Urologic Drugs Advisory Committee / FCP Senior Clinical Pharmacologist office of Clinical Pharmacology / University of Maryland University College / Risk Management Advisory Committee / Center for Drug Evaluation and Research / office of New Drugs / FOOD AND DRUG ADMINISTRATION / office of Translational Sciences / Molecular & Cellular Biology Baylor College of Medicine Effectiveness Merrell Magelli / Center for Drug Evaluation / /

Person

Clarus Therapeutics / Julia Johnson / Clarus Therapeutics Safety Theodore Danoff / Clarus Therapeutics Unmet / Mark S. Hirsch / Al Habet / Hylton V. Joffe / Kalyani Bhatt / Robert Dudley / Effectiveness Merrell Magelli / /

Position

Chairperson / MS Designated Federal Officer / Director / Medical Affairs / Medical Team Leader / CEO and President / Director / Division of Bone / Professor of Medicine / Senior Vice President / Clinical and Medical Affairs / Director / /

Product

testosterone / /

SocialTag